News | Ultrasound Women's Health | November 19, 2018

QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018

Completes first joint installation of AI-based system for concurrent reading with Invenia ABUS from GE Healthcare

QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018

November 19, 2018 – QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (AI) computer-aided detection (CAD) system for concurrent reading of automated breast ultrasound (ABUS) exams, at the 104th Annual Radiological Society of North America (RSNA) meeting, Nov. 25-30, in Chicago. Being demonstrated for the first time since being approved, QVCAD reduces interpretation time of screening ABUS exams while maintaining diagnostic accuracy.  

In addition, QView successfully completed an installation of QVCAD at Northern Arizona Healthcare, the first joint installation with the Invenia ABUS system from GE Healthcare. Invenia ABUS is approved by the FDA for breast cancer screening as an adjunct to mammography for asymptomatic women with dense breasts. “We are excited to add the capability to offer ABUS as part of our comprehensive breast cancer screening program, which will help improve cancer detection for women with dense breasts. However, it was important that we implement with concurrent decision support from QVCAD to improve reading times while maintaining workflow and diagnostic confidence,” said Liz Palomino, MHA, RT, Northern Arizona Healthcare director of medical imaging, Flagstaff Medical Center, Sedona Medical Center, Verde Valley Medical Center and Verde Valley Medical Imaging Center.

Results from several clinical studies have shown that the addition of ABUS to screening mammography results in a significant increase in cancer detection in women with dense breasts. However, the interpretation of ABUS exams, with up to 2,000 images per case, is complex and time consuming, particularly for new users. According to results of a reader study published recently in the American Journal of Radiology, QVCAD reduced reader interpretation time by 33 percent while maintaining diagnostic accuracy.

Based on deep learning algorithms, the AI system is designed to detect suspicious areas of breast tissue with characteristics similar to breast lesions, and highlight suspicious area to distinguish potentially malignant lesions from normal breast tissue.  QVCAD is FDA-approved for use with ABUS systems and has received the CE mark for use with ABUS/ABVS systems.

To improve reader productivity, QVCAD provides synthetic 2-D images of all six volumetric datasets in a standard ABUS exam to provide an immediately visual overview of the case. The C-thru images, which are minimum intensity projections (MinIP), summarize each 3-D ABUS volume in a 2-D image. They bring attention to specific areas of interest by enhancement of radial spiculations and retraction patterns in coronal reconstructions, which are highly suggestive of breast cancer in ABUS. Users may select any CAD mark or area of interest on the C-thru image and the corresponding original ABUS images will be displayed, enabling users to efficiently review the entire ABUS case.

For more information: www.qviewmedical.com

Related Content

TeraRecon Receives FDA Clearance for Northstar AI Results Explorer
Technology | Artificial Intelligence | June 20, 2019
Advanced visualization and artificial intelligence (AI) technology provider TeraRecon has successfully completed a U.S...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
Washington Open MRI Chooses RamSoft’s PowerServer RIS/PACS
News | PACS | June 18, 2019
Washington Open MRI (WOMRI) has selected RamSoft’s PowerServer RIS/PACS (radiology information system/picture archiving...
Double Black Imaging Announces Expanded Display Line and Ergonomic Workstation Solutions

The DBI CL8MPS from Double Black Imaging

News | Flat Panel Displays | June 18, 2019
Double Black Imaging (DBI) and their Image Systems Division are releasing their new clinical and diagnostic display...
Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT
Technology | Computed Tomography (CT) | June 18, 2019
Canon Medical Systems USA Inc. has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
Konica Minolta Healthcare Introduces New Financing Services Program for Exa Enterprise Imaging
News | Enterprise Imaging | June 17, 2019
June 17, 2019 – Konica Minolta Healthcare Americas Inc.
Sectra Providing Centralized Regional Solution for Digital Pathology in the U.K.
News | Digital Pathology | June 14, 2019
Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for...